MedTrace Logo

Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis

NCT00224432 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2006-09-27

No results posted yet for this study

Summary

To study the effect of supplementation of a hydrolyzed formula with probiotic bacteria on clinical and immunological parameters in infants with AD with and without CMA and to compare effectiveness of different strains of probiotics.

Conditions

Interventions

DRUG

probiotics: Lactobacillus GG, lactobacillus Rhamnosus

Sponsors & Collaborators

  • Numico Research Wageningen, the Netherlands

    collaborator UNKNOWN

  • Groningen Research Institute for Asthma and COPD

    lead OTHER

Principal Investigators

  • Eric J Duiverman, MD, PhD · Dept of Pediatric Pulmonology, University Medical Center Groningen, The Netherlands

  • Marianne L Brouwer, MD · Dept of Pediatric Pulmonology, University Medical Center Groningen, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
0 Years
Max Age
5 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-03-31
Completion
2002-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00224432 on ClinicalTrials.gov